Ionis Pharmaceuticals, Inc. Current Income Tax Expense (Benefit)
Ionis Pharmaceuticals, Inc. (IONS) reported Current Income Tax Expense (Benefit) of $1.79 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-26
- Ionis Pharmaceuticals, Inc. current income tax expense (benefit) for fiscal 2025 was $1.79M.
- Ionis Pharmaceuticals, Inc. current income tax expense (benefit) for fiscal 2024 was -$6.17M, a 119.09% decline from fiscal 2023.
- Ionis Pharmaceuticals, Inc. current income tax expense (benefit) for fiscal 2023 was $32.32M, a 175.38% increase from fiscal 2022.
- Ionis Pharmaceuticals, Inc. current income tax expense (benefit) for fiscal 2022 was $11.74M.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $1.79M 10-K · filed 2026-02-26 |
| 2024-12-31 | -$6.17M 10-K · filed 2026-02-26 |
| 2023-12-31 | $32.32M 10-K · filed 2026-02-26 |
| 2022-12-31 | $11.74M 10-K · filed 2025-02-19 |
| 2021-12-31 | -$551.00K 10-K · filed 2024-02-21 |
| 2020-12-31 | $3.46M 10-K · filed 2023-02-22 |
| 2019-12-31 | $50.60M 10-K · filed 2022-02-25 |
| 2018-12-31 | -$630.00K 10-K · filed 2021-02-24 |
| 2017-12-31 | -$5.98M 10-K · filed 2020-03-02 |
| 2016-12-31 | $2.93M 10-K · filed 2019-03-01 |
| 2015-12-31 | $372.00K 10-K · filed 2018-02-28 |
| 2014-12-31 | -$4.03M 10-K · filed 2017-03-01 |
| 2013-12-31 | $2.00K 10-K · filed 2016-02-26 |
| 2012-12-31 | $2.00K 10-K · filed 2015-03-02 |
| 2011-12-31 | $11.00K 10-K · filed 2014-03-03 |
| 2010-12-31 | $92.00K 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |